Parallax Volatility Advisers, L.P. Editas Medicine, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$6.92 - $9.31 $1,384 - $1,862	-200 Reduced 50.0%	200 $1,000
Q2 2023 Aug 14, 2023	SELL	$6.36 - $11.47 $6,996 - $12,617	-1,100 Reduced 73.33%	400 $3,000
Q1 2023 May 15, 2023	BUY	$7.03 - $11.53 $7,030 - $11,530	1,000 Added 200.0%	1,500 $10,000
Q4 2022 Feb 14, 2023	BUY	$8.32 - $13.21 $1,664 - $2,642	200 Added 66.67%	500 $4,000
Q2 2022 Aug 15, 2022	SELL	$9.99 - $21.35 $1,998 - $4,270	-200 Reduced 40.0%	300 $4,000
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $1,408 - $2,763	100 Added 25.0%	500 $10,000
Q4 2021 Feb 14, 2022	SELL	$26.55 - $40.57 $416,835 - $636,949	-15,700 Reduced 97.52%	400 $11,000
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $1.93 Million - $3.59 Million	-49,200 Reduced 75.34%	16,100 $661,000
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $2.04 Million - $3.7 Million	65,300 New	65,300 $3.7 Million
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $2.77 Million - $8.65 Million	-102,500 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$28.06 - $37.16 $3.8 Million - $5.03 Million	-135,300 Reduced 56.9%	102,500 $2.88 Million
Q2 2020 Aug 14, 2020	BUY	$18.5 - $34.34 $2.55 Million - $4.73 Million	137,800 Added 137.8%	237,800 $7.04 Million
Q1 2020 May 15, 2020	BUY	$14.88 - $32.78 $1.49 Million - $3.28 Million	100,000 New	100,000 $1.98 Million

246

56.8M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $94.2M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.